musculoskeletal and connective tissue disorders
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Treatment of EGPA
Corticosteroids ) are added, the choice of which depends on the severity and the type of organ involvement, using the same general criteria for treatment of Granulomatosis with Polyangiitis (GPA) or Cardiac involvement as manifested by myocarditis with heart failure is the main cause of death in EGPA. Wechsler ME, Akuthota P, Jayne D, et al:Mepolizumabor placebo for eosinophilic granulomatosis with polyangiitis.N Engl J Med376(20):1921-1932, 2017. doi:10.1056/NEJMoa1702079 